1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Zymeworks Bc Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC) Zanidatamab, Letrozole, Tamoxifen - Breast Cancer, HER2-positive | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 20 | 2021-11-16 | 2026-08-24 |
| ZW25 in Women With Endometrial Cancers ZW25 - Endometrial Cancer, Carcinosarcoma | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 16 | 2020-08-12 | 2025-05-22 |
Breast Neoplasms (1) · Carcinosarcoma (1) · Endometrial Neoplasms (1)
Letrozole (1) · Tamoxifen (1) · zanidatamab (1)
United States (2)
Vicente Valero (1) · Vikky Makker, MD (1)